Rang	Name	Position
1	Dr. Peter P. Luo Ph.D.	Co- Founder, Chairman, CEO and President of R&D
2	Mr. Man Kin Tam M.B.A.	CFO & Director
3	Ms. Ling Zhou	Executive Director & Head of Human Resources
4	Dr. Qinghai Zhao Ph.D.	Chief Manufacturing Officer
5	Mr. Mickael Chane-Du	Chief Strategy Officer
6	Ms. Yan Li M.B.A.	Senior Vice President of Bioinformatics & Information Technology
7	Ms. Xiaohong She	Senior VP & Head of Clinical Operations
8	Dr. Guizhong Liu Ph.D.	Senior Vice President of Early Drug Discovery
9	Mr. Alexander Goergen	VP & Head of Business Development
10	Dr. Jiping Zha M.D., Ph.D.	Executive Vice President of Clinical Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Jupiter Topco LLC	9,93%	13,73 Mio. USD
2	Siren, L.L.C.	3,97%	5,49 Mio. USD
3	Deerfield Management Co	3,97%	5,49 Mio. USD
4	Ameriprise Financial Inc	2,56%	3,54 Mio. USD
5	HSG Holding Ltd	2,00%	2,77 Mio. USD
6	Squadron Capital Management LLC	1,86%	2,58 Mio. USD
7	Dauntless Investment Group, LLC	0,80%	1,11 Mio. USD
8	Citadel Advisors Llc	0,76%	1,04 Mio. USD
9	Exome Asset Management LLC	0,73%	1,01 Mio. USD
10	Birchview Capital, LP	0,36%	0,49 Mio. USD
11	Moneta Group Investment Advisors Inc	0,30%	0,41 Mio. USD
12	Pathstone Holdings LLC	0,30%	0,41 Mio. USD
13	Mill Creek Capital Advisors LLC	0,30%	0,41 Mio. USD
14	Renaissance Technologies Corp	0,22%	0,30 Mio. USD
15	UBS Group AG	0,18%	0,26 Mio. USD
16	The Goldman Sachs Group Inc	0,16%	0,22 Mio. USD
17	Quadrature Capital Limited	0,12%	0,17 Mio. USD
18	Marshall Wace Asset Management Ltd	0,10%	0,14 Mio. USD
19	Amvescap Plc.	0,06%	0,09 Mio. USD
20	SmartHarvest Portfolios, LLC	0,06%	0,09 Mio. USD